Breakthrough T1D logo
Research Funding Opportunities (Topic RFAs)

RFA: Translational Strategies to Define & Monitor Vascularization for Islet Therapies

Funds translational methods to define, monitor, and improve vascularization in islet-based diabetes therapies.

ClosedBreakthrough T1DUnited States
View on funder site
About

Breakthrough T1D — the former JDRF, rebranded in June 2024 — issued this FY26 RFA on "Translational Strategies to Define and Monitor Vascularization for Islet Therapies" as part of its ongoing investment in the scientific infrastructure required for successful beta cell replacement. Vascularization — the integration of transplanted islets into the host vasculature — is a key determinant of graft s…

What this grant funds

Translational research defining and monitoring vascularization as a biological determinant of outcomes in islet cell transplantation and replacement therapies for type 1 diabetes.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.One-off
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Application process

Sign up free to see how to apply

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Last verified: 22 Jul 2026Source: www.breakthrought1d.org